EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cascade genetic testing: an underutilized pathway to equitable cancer care?

Roni Nitecki Wilke, Erica M Bednar, Sara Pirzadeh-Miller, Sayoni Lahiri, Isabel C Scarinci, Charles A Leath Iii, Melissa K Frey, Karen H Lu, J Alejandro Rauh-Hain

Familial Cancer · 2024

DOI: 10.1007/s10689-024-00367-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Familial Cancer, 2024. Verfasst von Roni Nitecki Wilke und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Drive, 77030-13…. Hauptthemen laut MEDLINE: Genetic Testing, Genetic Predisposition to Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS, The National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingGenetic Predisposition to DiseaseHumansFemalePrecision MedicineGerm-Line MutationGenetic CounselingNeoplasmsOvarian NeoplasmsBreast Neoplasms

Autor:innen und Institutionen

  • Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Drive, 77030-1362, Houston, TX, USA. rnitecki@mdanderson.org.
  • Cancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cancer Genetics, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA.

Förderung

  • NCATS NIH HHS
  • NCI NIH HHS
  • The National Institutes of Health National Cancer Institute
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Wilke, R. N., Bednar, E. M., Pirzadeh-Miller, S., Lahiri, S., Scarinci, I. C., Leath Iii, C. A., Frey, M. K., Lu, K. H., & Rauh-Hain, J. A. (2024). Cascade genetic testing: an underutilized pathway to equitable cancer care?. Familial Cancer. https://doi.org/10.1007/s10689-024-00367-2

Vancouver

Wilke RN, Bednar EM, Pirzadeh-Miller S, Lahiri S, Scarinci IC, Leath Iii CA, et al. Cascade genetic testing: an underutilized pathway to equitable cancer care?. Familial Cancer. 2024. doi:10.1007/s10689-024-00367-2

BibTeX
@article{Wilke2024,
  author = {Wilke, Roni Nitecki and Bednar, Erica M and Pirzadeh-Miller, Sara and Lahiri, Sayoni and Scarinci, Isabel C and Leath Iii, Charles A and Frey, Melissa K and Lu, Karen H and Rauh-Hain, J Alejandro},
  title = {Cascade genetic testing: an underutilized pathway to equitable cancer care?},
  journal = {Familial Cancer},
  year = {2024},
  doi = {10.1007/s10689-024-00367-2}
}
Kostenlos starten →